Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Twilio Inc (TWLO) Stock Is Many Things, But It’s Not Dependable

Twilio stock can't get any love despite putting up a strong beat in Q3, which means something might be amiss at TWLO.

3 Russian Stocks That Donald Trump Will Make Great Again

The heavily embattled campaign of Donald Trump just got an unlikely second wind, and Russian stocks couldn't be more relieved.

Wall Street’s Loss on Nike Inc (NKE) Stock Is Definitely Your Gain

Merrill Lynch may have shocked the markets with their bearish call on Nike stock, but following that advice on NKE is like playing with fire.

GoPro Inc (GPRO) Stock Won’t Get Help Anytime Soon

It's not looking good for GoPro stock. This is true as GPRO is getting a beat down right before a critical earnings release.

Walt Disney Co (DIS) Stock Fears Are Way Overblown

ESPN subscriptions and the general decline of sports viewership aren't encouraging, but DIS stock has faced far worse challenges.

Amazon.com, Inc’s (AMZN) Earnings Miss Is Much Ado About Nothing

AMZN stock absorbed one of the worst blows of this year, but abandoning the ship that Amazon built would be a big mistake.

3 Ag Stocks That Will Surprise Investors in 2017

Ag stocks have been one of the worst-hit sectors in recent years, but signs of an industry-wide recovery have investors hungry for more.

3 Discount Airline Stocks That Are Hitting Strong Turbulence

Discount airline stocks face a host of challenges that will continue to pressure them even if they emerge from earnings season victorious.

3 Hotel Stocks That Could Be All Smoke and Mirrors

The huge equity splurge by China's HNA Group means nothing for hotel stocks like Marriott (MAR), Hyatt (H) and LaSalle (LHO).

3 Big Pharma Stocks That Are Looking a Little Pale

These Big Pharma stocks need to justify their big price tags after disappointing results: Bristol-Myers (BMY), Merck (MRK) and Eli Lilly (LLY).